The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 830-837

  Wilson, R Paul ^a   Winter, Sebastian E ^a   Spees, Alanna M ^a   Winter, Maria G ^a   Nishimori, Jessalyn H ^a,b   Sanchez, Jesus F ^a   Nuccio, Sean Paul ^a   Crawford, Robert W ^a   Tükel, Çagla ^a,b   Bäumler, Andreas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR; UNCLASSIFIED DRUG; VI CAPSULAR POLYSACCHARIDE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; INNATE IMMUNITY; LIVER; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SALMONELLA TYPHI; SEROTYPE; SPLEEN; TYPHOID FEVER;

ANIMALS; CARBOHYDRATE CONFORMATION; COMPLEMENT C3; GENE EXPRESSION REGULATION, BACTERIAL; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES; MICE; MICE, INBRED C57BL; O ANTIGENS; POLYSACCHARIDES, BACTERIAL; PROTEIN BINDING; RECEPTORS, COMPLEMENT; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHI; SPLEEN;

EID: 79251517374     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00961-10     Document Type: Article

References (39)

1. Alvarez, D., S. Merino, J. M. Tomas, V. J. Benedi, and S. Alberti. 2000. Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect. Immun. 68:953-955.
2. Brown, E. J., K. A. Joiner, R. M. Cole, and M. Berger. 1983. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect. Immun. 39:403-409.
3. Bueno, S. M., et al. 2004. Precise excision of the large pathogenicity island, SPI7, in Salmonella enterica serovar Typhi. J. Bacteriol. 186:3202-3213.
4. Clark, T. W., C. Daneshvar, M. Pareek, N. Perera, and I. Stephenson. 2010. Enteric fever in a UK regional infectious diseases unit: a 10 year retrospective review. J. Infect. 60:91-98.
5. Crump, J. A., S. P. Luby, and E. D. Mintz. 2004. The global burden of typhoid fever. Bull. World Health Organ. 82:346-353.
6. Cunnion, K. M., J. C. Lee, and M. M. Frank. 2001. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect. Immun. 69:6796-6803.
7. Cunnion, K. M., H. M. Zhang, and M. M. Frank. 2003. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect. Immun. 71:656-662.
8. Felix, A., and R. M. Pitt. 1934. A new antigen of B. typhosus. Lancet 227:186-191.
9. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41:1089-1098.
10. Glynn, A. A., and C. J. Howard. 1970. The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology 18:331-346.
11. Haneda, T., et al. 2009. The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism. Infect. Immun. 77:2932-2942.
12. Hashimoto, Y., and A. Q. Khan. 1997. Comparison of ViaB regions of Vi-positive organisms. FEMS Microbiol. Lett. 157:55-57.
13. Heyns, K., and G. Kiessling. 1967. Strukturaufklarung des Vi-antigens aus Citrobacter freundii (E. coli) 5396/38. Carbohydr. Res. 3:340-353.
14. Hone, D. M., A. M. Harris, V. Lim, and M. M. Levine. 1994. Construction and characterization of isogenic O-antigen variants of Salmonella typhi. Mol. Microbiol. 13:525-530.
15. Horwitz, M. A., and S. C. Silverstein. 1980. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J. Clin. Invest. 65:82-94.
16. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55:174-180.
17. Johnson, E. M., B. Krauskopf, and L. S. Baron. 1965. Genetic mapping of Vi and somatic antigenic determinants in Salmonella. J. Bacteriol. 90:302-308.
18. Kingsley, R. A., and A. J. Bäumler. 2000. Host adaptation and the emergence of infectious disease: the salmonella paradigm. Mol. Microbiol. 36:1006-1014.
19. Klugman, K. P., et al. 1987. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet ii:1165-1169.
20. Looney, R. J., and R. T. Steigbigel. 1986. Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J. Lab. Clin. Med. 108:506-516.
21. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
22. Nair, S., et al. 2004. Salmonella enterica serovar Typhi strains from which SPI7, a 134-kilobase island with genes for Vi exopolysaccharide and other functions, has been deleted. J. Bacteriol. 186:3214-3223.
23. Olsen, S. J., et al. 2003. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol. Infect. 130:13-21.
24. Parkhill, J., et al. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848-852.
25. Pullinger, G. D., et al. 2007. Systemic translocation of Salmonella enterica serovar Dublin in cattle occurs predominantly via efferent lymphatics in a cell-free niche and requires type III secretion system 1 (T3SS-1) but not T3SS-2. Infect. Immun. 75:5191-5199.
26. Raffatellu, M., et al. 2006. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 74:19-27.
27. Raffatellu, M., et al. 2007. The capsule encoding viaB locus reduces interleukin- 17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect. Immun. 75:4342-4350.
28. Raffatellu, M., R. P. Wilson, S. E. Winter, and A. J. Bäumler. 2008. Clinical pathogenesis of typhoid fever. J. Infect. Dev. Ctries. 2:260-266.
29. Robbins, J. D., and J. B. Robbins. 1984. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J. Infect. Dis. 150:436-449.
30. Rolan, H. G., and R. M. Tsolis. 2007. Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization. Infect. Immun. 75:2965-2973.
31. Sahu, A., T. R. Kozel, and M. K. Pangburn. 1994. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem. J. 302(Pt 2):429-436.
32. Tacket, C. O., et al. 1986. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154:342-345.
33. Tsolis, R. M., G. M. Young, J. V. Solnick, and A. J. Bäumler. 2008. From bench to bedside: stealth of enteroinvasive pathogens. Nat. Rev. Microbiol. 6:883-892.
34. Tükel, C., et al. 2005. CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol. Microbiol. 58:289-304.
35. Van Dijk, W. C., H. A. Verbrugh, M. E. van der Tol, R. Peters, and J. Verhoef. 1979. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect. Immun. 25:603-609.
36. Virlogeux, I., H. Waxin, C. Ecobichon, and M. Y. Popoff. 1995. Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology 141(Pt 12):3039-3047.
37. WHO. 1997. The world health report 1996 - fighting disease, fostering development. World Health Forum 18:1-8.
38. Winter, S. E., A. M. Keestra, R. M. Tsolis, and A. J. Bäumler. 2010. The blessings and curses of intestinal inflammation. Cell Host Microbe 8:36-43.
39. Winter, S. E., M. Raffatellu, R. P. Wilson, H. Russmann, and A. J. Bäumler. 2008. The Salmonella enterica serotype Typhi regulator TviA reduces interleukin- 8 production in intestinal epithelial cells by repressing flagellin secretion. Cell. Microbiol. 10:247-261.